Your browser doesn't support javascript.
loading
African-specific polymorphisms in Plasmodium falciparum serine repeat antigen 5 in Uganda and Burkina Faso clinical samples do not interfere with antibody response to BK-SE36 vaccination.
Arisue, Nobuko; Palacpac, Nirianne Marie Q; Ntege, Edward H; Yeka, Adoke; Balikagala, Betty; Kanoi, Bernard N; Bougouma, Edith Christiane; Tiono, Alfred B; Nebie, Issa; Diarra, Amidou; Houard, Sophie; D'Alessio, Flavia; Leroy, Odile; Sirima, Sodiomon B; Egwang, Thomas G; Horii, Toshihiro.
Afiliación
  • Arisue N; Research Center for Infectious Disease Control, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
  • Palacpac NMQ; Section of Global Health, Division of Public Health, Department of Hygiene and Public Health, Tokyo Women's Medical University, Tokyo, Japan.
  • Ntege EH; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.
  • Yeka A; Department of Plastic and Reconstructive Surgery, University of the Ryukyus, Graduate School of Medicine and Hospital, Okinawa, Japan.
  • Balikagala B; Makerere University School of Public Health, Kampala, Uganda.
  • Kanoi BN; Department of Tropical Medicine and Parasitology, School of Medicine, Juntendo University, Tokyo, Japan.
  • Bougouma EC; Centre for Malaria Elimination (CME) and Centre for Research in Infectious Diseases (CRID), Directorate of Research and Innovation, Mount Kenya University, Thika, Kenya.
  • Tiono AB; Public Health Department, Institut National de Santé Publique/Centre National de Recherche et de Formation sur le Paludisme (INSP/CNRFP), Ouagadougou, Burkina Faso.
  • Nebie I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Diarra A; Public Health Department, Institut National de Santé Publique/Centre National de Recherche et de Formation sur le Paludisme (INSP/CNRFP), Ouagadougou, Burkina Faso.
  • Houard S; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • D'Alessio F; Public Health Department, Institut National de Santé Publique/Centre National de Recherche et de Formation sur le Paludisme (INSP/CNRFP), Ouagadougou, Burkina Faso.
  • Leroy O; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Sirima SB; Public Health Department, Institut National de Santé Publique/Centre National de Recherche et de Formation sur le Paludisme (INSP/CNRFP), Ouagadougou, Burkina Faso.
  • Egwang TG; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Horii T; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany.
Front Cell Infect Microbiol ; 12: 1058081, 2022.
Article en En | MEDLINE | ID: mdl-36590593
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Malaria Falciparum / Vacunas contra la Malaria Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Africa Idioma: En Revista: Front Cell Infect Microbiol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Malaria Falciparum / Vacunas contra la Malaria Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Africa Idioma: En Revista: Front Cell Infect Microbiol Año: 2022 Tipo del documento: Article